Bioservo Technologies secures an additional order regarding delivery and implementation of the Ironhand®-system, from an existing international customer in the automotive sector. The order value is estimated at approximately SEK 800,000 thousand. After two years of successful tests and evaluation of Bioservo’s technology, the customer placed a first order in August, and now chooses to accelerate the implementation of the Ironhand®-system allowing them to advance further regarding human-robot interaction in its factories.
Ironhand® is the world’s first soft robotic muscle strengthening system for professional users. Ironhand® strengthens the worker’s grip and stamina and has been developed to prevent and detect the risk of stress injuries in grip-intensive and repetitive work operations.
Bioservo believes digital human augmentation is the way forward in creating an ergonomic and sustainable work environment and thus profitability through corporate responsibility.
“We are happy to receive a consecutive order for Ironhand® within such a short period of time. It is further proof that Ironhand® gives a clear advantage in the work environment through its combination of power amplification and digitalization. We see a strong and increasing demand for our concept across many industries”, says Petter Bäckgren, CEO Bioservo Technologies.
About Bioservo Technologies AB
Bioservo Technologies (publ) is a technology and development company that combines medical science with modern robotics. The company has a leading global position within soft exoskeleton technology, wearable non-invasive products, for people in need of extra power to support the body's endurance and performance, or for people with reduced muscular strength.
After many years of research and development, Bioservo Technologies now focus on the commercialization of its products and patented technologies. The developed gloves are well suited for both rehabilitation within health and medical care and preventively for professionals in the industry. The company has signed strategic cooperation agreements with several multinational companies within e.g. the automobile, aircraft as well as the construction and infrastructure industry.
Bioservo Technologies was founded in 2006 through a collaboration between researchers at the Royal Institute of Technology and doctors at Karolinska University Hospital in Stockholm. Bioservo Technologies is a Swedish public company with headquarters and operations in Kista, north of Stockholm. FNCA Sweden AB is the company's Certified Adviser on Nasdaq First North.
For more information, please visit www.bioservo.se
Bioservo Technologies AB Press Contacts
Tel.: +46 (0)70 555 69 97
Sales and Marketing Director
Tel.: +46 (0)70 467 57 84
Powered by WPeMatico